US NCI (National Cancer Institute) completes lung cancer trial enrolment:
This article was originally published in Clinica
Executive Summary
The National Cancer Institute has enrolled the hoped-for 50,000 persons into the National Lung Screening Trial to test whether early screening can reduce deaths from lung cancer. The participants - all current and former smokers with no apparent symptoms of lung cancer - will be screened with either spiral computed tomography or chest X-ray once a year for three years, and then be contacted annually until 2009. Although the full complement of participants has been enrolled, the trial will remain open at selected sites to collect blood, urine and sputum to help doctors identify biomarkers of lung cancer, said the research institute, which is working in partnership with the American Cancer Society.